Clinical trial
Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
NCT00004471 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 1995
- Completion date
- Not reported
- Enrollment
- 9
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.